Genetic Polymorphisms Associated with Insulin Resistance Risk in Normal BMI Indians

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by Answer Genomics Pvt Limited.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol received approval from the Answer Genomics Ethical Review Committee. REF.NO.:10/NRT/23-24 AERC Number:10001/AERC/24 I am pleased to inform you that the aforementioned study has been approved by the Answergenomics Ethical Review Committee (AERC) in accordance with the compliance of the Section 4, National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, ICMR (2017). All research activities must be conducted in accordance with the approved submission. It is your responsibility to fulfil the following requirements of approval: 1. Changes, amendments and addenda to the protocol, informed consent, or other study materials must be submitted to AERC for re-review and approval prior to implementation. 2. Any unanticipated problems, adverse events, protocol violations, social harm, or any new information becoming available which could change the risk/benefit ratio must be reported to the AERC. The AERC concluded that the Principal Investigator has taken sufficient safeguards to carry out the study. Therefore, the AERC approves the proposal for conducting the survey submitted in the protocol. This approval is based on your submission of study protocol (refer email sabitha@nugenomics.in dated 29/12/2024) Any deviation from this protocol will require further approval of the AERC. This is valid for one year from the date of approval, mentioned geographical location and presented sample. After the completion of the study, please submit the study report to the AERC.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes